Astra cheers Crestor patent victory
30th Jun 2010 07:07
Shares in AstraZeneca jumped nearly 10% after the Anglo-Swedish drugs giant received a favourable US ruling in its battle to keep control of the patents to its best-selling cholesterol-lowering drug Crestor. The ruling means that cheaper, generic versions of Astra's blockbuster drug can not enter t
Read moreMARKET TALK: UBS Ups AstraZeneca Target After Crestor Victory
30th Jun 2010 07:07
0607 GMT [Dow Jones] UBS raises AstraZeneca (AZN.LN) price target to 4100p from 3800p after it successfully defends its U.S. Crestor patent. Says this victory significantly safeguards around 17% of earnings, at risk due to the Crestor trial. From here, expects earnings momentum to continue. Says wit
Read moreUK MARKET TALK ROUNDUP: BROKERS COMMENTS
30th Jun 2010 07:07
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0607 GMT [Dow Jones] UBS raises AstraZeneca (AZN.LN) price target to 4100p from 3800p after it successfully defends its U.S.
Read moreWednesday's newspaper round-up: Budget cuts, BP, AstraZeneca
30th Jun 2010 06:42
George Osborne's austerity budget will result in the loss of up to 1.3m jobs across the economy over the next five years according to a private Treasury assessment of the planned spending cuts. Unpublished estimates of the impact of the biggest squeeze on public spending since the second world war
Read moreCORRECT: US Judge Upholds Patent For AstraZeneca's Crestor >AZN
29th Jun 2010 23:05
("US Judge Upholds Patent For AstraZeneca's Crestor" published at 5:08 p.m. EDT incorrectly implied in the third paragraph that global sales for Crestor in 2009 were $2.1 billion. That was the U.S. sales figure. A corrected version follows:) By Peter Loftus Of DOW JONES NEWSWIRES PHILADE
Read moreUPDATE: US Judge Upholds Patent For AstraZeneca's Crestor >AZN
29th Jun 2010 23:05
(Adds details about patent expiration in second paragaph; stock price in fourth paragraph; analyst reaction in fifth graph; additional details.) By Peter Loftus Of DOW JONES NEWSWIRES PHILADELPHIA (Dow Jones)--A U.S. judge has ruled that the patent for AstraZeneca PLC's (AZN, AZN.LN) blo
Read moreLondon close: Footsie dives on economic concerns
29th Jun 2010 16:31
London's leading shares ended with heavy losses as concerns about the global economy resurfaced again. Traders were nervy in Europe about bank payments that need to be made to the European Central Bank this week, while triple-digit falls on Wall Street added to London's woes. As in London, US in
Read moreLondon afternoon: Stocks dive deeper
29th Jun 2010 14:27
Expectations of a triple-digit fall on the Dow Jones index when Wall Street opens has added to London's woes. As in London, US investors are concerned that China's economy is not likely to grow at the rate previously anticipated. US based research group the Conference Board said overnight that its
Read moreLondon midday: Footsie waves goodbye to 5,000
29th Jun 2010 12:06
Footsie fell below 5,000 as mining shares tanked in the morning session on concerns that China's economy is not likely to grow at the rate previously anticipated. US based research group the Conference Board said its China leading economic index rose just 0.3% in April, a sharp revision down from
Read moreLondon open: Footsie slides lower
29th Jun 2010 08:56
London has followed US and Asian markets lower with only AstraZeneca in the blue at present. It was suggested as a possible takeover company for a US company by Standard & Poor's, along with BAE Systems and Balfour Beatty. US companies clearly are interested in UK assets judging from Emerson's 375
Read moreTuesday newspaper round-up: BP, AstraZeneca, Car industry
29th Jun 2010 06:43
Fresh tensions erupted between BP and the Kremlin last night after the British oil giant was forced to deny reports that Russia's Deputy Prime Minister had suggested its chief executive was on the verge of resignation. Just hours before Tony Hayward was due to meet Igor Sechin in Moscow for talks
Read moreAstraZeneca Pharma India Receives Delisting Offer From Founder
29th Jun 2010 04:48
MUMBAI (Dow Jones)--AstraZeneca Pharma India Ltd. (506820.BY) said Tuesday it has received a delisting offer from 90%-owner AstraZeneca Pharmaceuticals AB, sending its shares higher. The company didn't mention the delisting price, but said in a regulatory filing that its board will meet Tuesday
Read morePRESS RELEASE: CRESTOR® Patent Upheld By US Court
29th Jun 2010 00:06
WILMINGTON, Del., June 29 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) announced today that Judge Joseph Farnan, Jr., US District Court, District of Delaware, has found that the substance patent protecting CRESTOR (RE37,314 -- the '314 patent) is valid and enforceable. In its ruling, the court
Read moreUS HOT STOCKS: IDT, RehabCare, Smith & Wesson, Technitrol -2-
28th Jun 2010 22:01
IDT Corp. (IDT, $11.37, +$1.58, +16.14%), a company that only regained New York Stock Exchange compliance in April, made a splash at the exchange on Monday. The holding company, which focuses on telecommunications services but is turning more attention to energy services, rang the opening bell Monda
Read moreTeva Launches Generic Version Of AstraZeneca Breast-Cancer Drug
28th Jun 2010 19:55
DOW JONES NEWSWIRES Teva Pharmaceutical Industries Ltd. (TEVA, TEVA.TV) said it won approval from the U.S. Food and Drug Administration to commercially launch a generic version of AstraZeneca PLC's (AZN, AZN.LN) breast-cancer drug Arimidex. According to the generic-drug giant, AstraZeneca's
Read more